Information platform for Japanese Medicines

Index:: Categories Active ingredients Manufacturers Tags

Market information List of ethical pharmaceutical supply information

Sign up Log in

Sign up Log in

Index:: Categories Active ingredients
Manufacturers Tags

Market information List of ethical pharmaceutical supply information

Top
Agents against pathologic organisms and parasites
Biological preparations
Miscellaneous
Others
ULTOMIRIS for Intravenous Infusion 300mg

ULTOMIRIS for Intravenous Infusion 300mg

Manufacturer: Alexion

Packages: 1 vial × 1 vial = 1 vial

Tags: Powerful drug; Biological products; Brand

Different Standards/Packaging Product

1 vial × 1 vial = 1 vial

Check all

Detailed information

1 vial × 1 vial = 1 vial

ULTOMIRIS for Intravenous Infusion 300mg

Branded Name: ULTOMIRIS for Intravenous Infusion 300mg
Generic Name: Ravulizumab (Genetical Recombination)
Heat Number / Carved Seal: N/A
Form / Color: - / -
Date of Transitional Measures: 2024-03-31T00:00:00Z
Ministry of Health and Welfare Code: 6399427A1027
YJ Code: 6399427A1027
Manufacturer: Alexion
MA holder: Alexion
Restriction Information: Powerful drug
Storage Condition: -
Cautions for Storage: -
Brand / Authorized Generic / Generic: Brand
Biological Origin / Biosimilar: Biological products
Strength: 300 ｍｇ
Prescription Drug: Yes
Followed by Generic: not available
Effective date: 000 00, 0000
Lot No.: 00000000
Lead time: X days

Created at

2021-09-02T03:08:06Z

Updated at

2024-10-22T05:10:02Z

Japanese notation

Product Name: ユルトミリス点滴静注３００ｍｇ
Name of Manufacturer: アレクシオンファーマ
Name of MA Holder: アレクシオンファーマ
Form / Color: 注射液 / -

Alternative pharmaceuticals

*About alternative pharmaceuticals...This information is based on the active ingredients, dosage form, and specifications/units. It does not necessarily mean that the product is currently available.

No alternative pharmaceuticals found.

1. PRESCRIPTION

“ULTOMIRIS for Intravenous Infusion 300mg” is a prescription medicine (Rx) in Japan.

2. IMPORT(SUPPORTING) DOCUMENTS

Certificate of Origin (CoO), Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) of “ULTOMIRIS for Intravenous Infusion 300mg” are available.
*PIL and SmPC are written in Japanese.

3. Clinical trials

Search on-going Clinical Trials of “ULTOMIRIS for Intravenous Infusion 300mg” on International Clinical Trials Registry Platform (ICTRP) Search Portal provided by WHO.
https://apps.who.int/trialsearch/

4. Price

Offering price is based on Ex Works. Currency can be chosen USD, EUR or JPY.

5. Shipment

Please arrange delivery with your favorite couriers or forwarders.
Temperature controlled box and temperature logger is available. Please let us know if needed.

6. Our process

1. Upload your license and make an inquiry

Use the search bar on Synapse to search by the product's name, active ingredient, or manufacturer. You can also view medicines by therapeutic categories. Once on the product page, click on "Add to My List" to inform us of your preferences and details. The more information you provide, the better we can assist you. We also accept general inquiries on the Contact Us page. Please submit your license.
Submit your License.

2. Receive a quote

You will receive a detailed quote, which is the Ex Works price.

3. Place an order

You can order the required products based on the provided quote.

4. We send a Proforma Invoice and prepare for delivery.

Upon receiving your purchase order (PO), we will send you a Proforma Invoice with payment details. Once the payment is received, we will process your order. Our experienced sourcing and logistics team will procure your products and prepare for shipping.